Patient-Reported Outcomes (Pros) from Destiny-Breast04, a Randomized Phase Iii Study of Trastuzumab Deruxtecan (T-Dxd) Vs Treatment of Physician's Choice (Tpc) in Patients (Pts) with Her2-Low Metastatic Breast Cancer (Mbc)

AuthID
P-00X-M28
20
Author(s)
Ueno, NT
·
Jacot, W
·
Yamashita, T
·
Sohn, J
·
Tokunaga, E
·
Prat, A
·
Tsurutani, J
·
Park, YH
·
Xu, B
·
Cardoso, F
·
Mitri, Z
·
Mahtani, R
·
Dunton, K
·
Wang, Y
·
Gambhire, D
·
Cottone, F
·
Harbeck, N
·
Cameron, DA
·
Modi, S
Document Type
Abstract
Year published
2022
Published
in ANNALS OF ONCOLOGY, ISSN: 0923-7534
Volume: 33, Issue: 7, Pages: S632-S633 (2)
Conference
Annual Meeting of the European-Society-For-Medical-Oncology (Esmo), Date: SEP 09-13, 2022, Location: ELECTR NETWORK, Sponsors: European Soc Med Oncol
Indexing
Publication Identifiers
Wos: WOS:000866211600206
Source Identifiers
ISSN: 0923-7534
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.